S

Sarepta

Develops gene therapies for rare diseases

Manager – Global Regulatory Strategy

Regulatory & Quality (Life Sciences)Posted on Nov 14
Full-timeCambridge, MA, USA$116k - $145k /yr

About the Job

Requirements

  • Knowledge of drug development and the regulatory process.
  • Knowledge of ICH guidelines, IND/CTA, IMPDs, and orphan drug designation.
  • Demonstrated experience preparing submissions, with a clear understanding of submission content and format requirements.
  • Ability to successfully multitask, prioritize, manage projects and timelines, and organize and track complex information.
  • Experience working in cross-functional project teams.
  • Proficiency with Microsoft Office applications, including Word, Excel, and Outlook, and Adobe Suite systems.

Responsibilities

  • Participate in clinical and nonclinical regulatory strategic discussions and support multiple products’ clinical trial and registration activities.
  • Execute regulatory activities cross-functionally at the team level to support assigned programs and markets.
  • Support implementation of regulatory strategy for assigned markets and provide regulatory support for registration and post-licensing activities of medicinal products.
  • Maintain and develop knowledge of assigned market regulatory procedures.
  • Build and maintain relationships within GRA and with other stakeholders to support effective communication and efficient implementation of regulatory activities for assigned markets and activities.
  • Analyze issues and data by evaluating multiple factors and understanding current business trends.
  • Escalate and effectively communicate issues to supervisors and other relevant regulatory affairs stakeholders.
  • Follow processes and operational policies when selecting methods and techniques for obtaining solutions.
  • Work on objectives with meaningful impact on the unit and organization.

About the Company

Sarepta

Develops gene therapies for rare diseases

Sarepta Therapeutics focuses on developing precision genetic medicines to treat rare diseases. It specializes in Duchenne muscular dystrophy (DMD) and is advancing gene therapies for limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth disease, MPS IIIA, and other CNS disorders. The company conducts research and development, carries therapies through clinical trials, and seeks regulatory approvals to bring treatments to patients, earning revenue from approved therapies and strategic partnerships. Its goal is to speed up drug development from lab research to patient treatment and to build the world’s largest gene therapy manufacturing capacity to meet global demand.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Sarepta

See more jobs